公司資料
Celyad 股價、新聞與催化劑
- 股票代碼:
- CYAD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Belgium and traded in the U
股價為何變動
目前無法取得 CYAD 的收盤價變動背景。
公司概覽
業務概覽
Celyad was a cell-therapy company focused on CAR-T and immune-cell engineering before becoming a historical ticker. Its narrative centered on trying to develop next-generation allogeneic cell therapies for cancer.
所在地與產業分類
Celyad was headquartered in Belgium and traded in the U.S. market. It sat in cell therapy and oncology biotechnology.
商業模式特徵
The company depended on translational progress, manufacturing feasibility, and capital support in a difficult cell-therapy market. Investors historically watched early data and the company's ability to keep its platform alive.
生技產業定位
Celyad is a historical cell-therapy biotech name. It belongs to the category of platform companies that were highly dependent on scientific validation and financing.
未來催化劑
- Celyad’s catalysts are its CAR-T and cell-therapy assets, plus any strategic update that clarifies what remains after earlier setbacks. The market is watching for a cleaner path more than broad optionality.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。